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Abstract: Cryptosporidium parvum is a protozoan parasite that can cause moderate-to-severe diarrhea.
Insulinase-like proteases (INS) are one of the largest protein families within the small proteome of the
pathogen. However, their roles in C. parvum biology remain un-elucidated. In this study, a member of
the protein family, INS-15 of C. parvum encoded by cgd3_4260, was cloned, expressed and characterized
to understand its function. INS-15 and its domain I were expressed in Escherichia coli and polyclonal
antibodies against the domain I and one specific polypeptide were prepared in rabbits. The role of
INS-15 protein in the C. parvum invasion was preliminarily studied. Recombinant INS-15 protein
and its domain I were successfully expressed in E. coli, together with various degraded products.
The cgd3_4260 gene had a peak expression at 2 h of in vitro C. parvum culture, while the INS-15 protein
was expressed in the mid-anterior region of sporozoites and the area of merozoites opposite to the
nucleus. Anti-INS-15 domain I antibodies reduced the invasion of C. parvum sporozoites by over 40%.
The anterior location of INS-15 in invasion stages and partial reduction of in vitro growth indicate
that INS-15 plays some roles in the invasion or early development of C. parvum.
Keywords: Cryptosporidium parvum; insulinase-like protease; expression; invasion
1. Introduction
Cryptosporidium spp. are apicomplexan parasites that have emerged as an important cause of
diarrhea in humans and animals [1]. They infect all vertebrates, causing watery diarrhea in young
animals, especially pre-weaned calves and lambs [2]. In addition, cryptosporidiosis is one of the
top five causes of moderate-to-severe diarrhea in children younger than two years in developing
countries [3,4]. In 2016 alone, acute cryptosporidiosis in children under five has led to more than
4.2 million disability-adjusted life-years (DALYs) lost and more than 48,000 deaths globally [5]. Most
human Cryptosporidium infections are caused by C. hominis and C. parvum, which differ in host range [6].
The former mainly infects humans while the latter infects humans, ruminants and some other animals.
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The lack of effective drugs against cryptosporidiosis is largely due to our limited understanding
of the biology of Cryptosporidium spp., especially the invasion process. Nitazoxanide is the only drug
approved by the US Food and Drug Administration (FDA) for the treatment of cryptosporidiosis, but
it is ineffective in immunocompromised individuals [7]. Cryptosporidium spp. have a complex life cycle
including excystation, adhesion, invasion, and intracellular multiplication during early stages of the
infection [8]. In addition, the molecular mechanisms of the invasion in Cryptosporidium spp. appear to
be significantly different from Toxoplasma gondii and Plasmodium spp. [9]. To facilitate the development
of effective control measures, efforts have been made to identify and characterize proteins involved in
the early interactions between the pathogens and host cells, with over 30 candidates being identified
thus far [10,11].
Secreted proteases and protein kinases released by secretory organelles of apicomplexans are
known to be involved in processing invasion-related proteins or modifying host cell activities during
the invasion of the host [12]. Insulinase-like proteases (INS) belonging to the M16 superfamily of
metalloproteases are members of this large group of enzymes. A classic M16 protease normally
contains four domains: one active domain characterized by the presence of an inverted zinc-binding
motif HxxEH (where x can be any amino acid) as well as three inactive catalytic domains [13]. Human
insulinase can cleave a variety of peptides, such as insulin, β-endorphin, and amyloid β-protein.
INS members are reportedly localized in cytosol, peroxisomes, endosomes and even on the surface
of cells [14], suggesting a broad range of functions by these enzymes. INS proteins have also been
found in other apicomplexans, such as T. gondii [15,16] and Plasmodium falciparum [17]. They may play
important roles in the invasion and early development of these pathogens.
Results of comparative genomics analyses indicate that INS proteases are common in
Cryptosporidium spp., with 12–22 genes being identified in different species, including INS-15 and
INS-16. For example, C. parvum has 22 INS proteins [10], 13 of which are expressed at high levels
during early infection [18]. Most of them belong to the M16A subfamily, except for two M16B proteins
and one M16C protein. Although C. hominis is genetically related to C. parvum, at least two of the INS
genes are missing in its genome, suggesting that INS could play a potential role in determining some
phenotypic differences between the two species [10]. A recent study of one C. parvum-specific INS, the
INS-20-19 encoded by a subtelomeric gene (cgd6_5520_5510) in chromosome 6, has shown that indeed
these proteins could be involved in the invasion and early growth of the pathogen [19]. INS-20-19,
however, does not have all 4 domains present in classic INS.
In this study, we have focused on the INS-15 encoded by the cgd3_4260 gene. It was chosen
because it is encoded by one member of the 11-gene cluster on chromosome 3 and has all 4 domains
that are present in classic M16A metalloproteases, other INS proteases in Cryptosporidium spp. mostly
have one or more domains missing. As INS-15 has significant sequence homology (90% nucleotide
sequence identity) to INS-16 encoded by the cgd3_4270 gene, which is absent in C. ubiquitum, it may
have important biologic functions in Cryptosporidium spp.
2. Results
2.1. Expression of Recombinant INS-15 and INS-15 Domain I
The full cgd3_4260 gene and its domain I fragment (Figure 1a) were amplified by PCR (Figure 2a,c)
and cloned into the pET-28a vector. The recombinant INS-15 and INS-15 domain I generated were
purified using the His-tag incorporated (Figure 2b,d). In SDS-PAGE analysis of the recombinant
INS-15, the expected band with the predicted size of ~130 kDa was seen. However, there were also
several bands smaller than 130 kDa. The INS-15 identity of the 130 kDa, ~40 kDa, ~25 kDa bands
were confirmed using MALDI-TOF-MS analysis, yielding peptide sequences of INS-15 (Accession No.
XM_626969, date not shown). In SDS-PAGE analysis of the INS-15 domain I, the expected band of the
predicted size of ~25 kDa was seen. Similarly, there was another band of ~23 kDa. The INS-15 identity
of both bands was also confirmed by the results of the MALDI-TOF-MS analysis.
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Figure 1. Sequence features of INS-15. (a) Diagram of INS-15 of Cryptosporidium parvum illustrating the
presence of one M16 active domain, two inactive domains, and one middle or third domain. The black
line identifies the domain I. (b) Alignment of partial amino acid sequences of INS-15 and INS-16 from
C. parvum. The red box shows the differences in amino acid sequences between NS-15 and INS-16 in








   
(d) 
 
Figure 2. Expression of full-length INS-15 and its domain I in Escherichia coli. (a) PCR amplification of 
the cgd3_4260 gene of C. parvum. Lane M: 1000 bp molecular makers, Lane 1: cgd3_4260 product. (b) 
SDS-PAGE analysis of full-length INS-15 expressed in E. coli (left panel) and purified INS-15 protein 
from E. coli (right panel). Lane M: molecular weight markers, Lane 1: lysate from recombinant bacteria 
without isopropyl β-D-thiogalactoside (IPTG) induction, Lane 2: lysate from recombinant bacteria 
after IPTG induction, with the expected product indicated by an arrow, Lane 3: INS-15 purified from 
the E. coli lysate using Ni-NTA affinity chromatography. (c) PCR amplification of the domain I 
fragment of the cgd3_4260 gene of C. parvum. Lane M: 100 bp molecular markers, Lane 1: cgd3_4260 
domain I product. (d) SDS-PAGE analysis of recombinant INS-15 domain I expressed in E. coli (left 
panel) and purified INS-15 domain I protein from E. coli (right panel). Lane M: molecular weight 
markers, Lane 1: lysate from E. coli culture without IPTG induction, Lane 2: lysate from E. coli culture 
after IPTG induction, with the expected product being indicated by an arrow, Lane 3: INS-15 domain 
I purified from the lysate using Ni-NTA affinity chromatography. 
2.2. Identification of Native INS-15 
To characterize native INS-15, antibodies against the INS-15 domain I and an INS-15 polypeptide 
were generated. In western blot analysis, antibodies against the INS-15 domain I reacted with a 
protein of ~140 kDa weakly and several proteins smaller than 100 kDa in lysates of C. parvum 
sporozoites, especially a band of ~23 kDa. As expected, they recognized the full-length 130 kDa 
recombinant protein, fragments of it and two bands of ~25 kDa and ~23 kDa in recombinant INS-15 
domain I (Figure 3a). The pre-immune serum did not react with any of these proteins, confirming the 
specificity of the antibodies to INS-15. Antibodies against INS-15 polypeptide produced similar 
profiles of reactivity to native and recombinant INS-15 proteins, although the reactivity to the ~23 
kDa band was much weaker compared with antibodies against domain I (Figure 3b). 
Figure 2. Expression of full-length INS-15 and its domain I in Escherichia coli. (a) PCR amplification
of the cgd3_4260 gene of C. parvum. Lane M: 1000 bp molecular makers, Lane 1: cgd3_4260 product.
(b) SDS-PAGE analysis of full-length INS-15 expressed in E. coli (left panel) and purified INS-15 protein
from E. coli (right panel). Lane M: molecular weight markers, Lane 1: lysate from recombinant bacteria
without isopropyl β-D-thiogalactoside (IPTG) induction, Lane 2: lysate from reco binant bacteria after
IPTG induction, with the expected product indicated by an arrow, Lane 3: INS-15 purified from the E. coli
lysate using Ni-NTA affinity chromatography. (c) PCR amplification of the domain I fragment of the
cgd3_4260 gene of C. parvum. Lane M: 100 bp molecular markers, Lane 1: cgd3_4260 domain I product.
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(d) SDS-PAGE analysis of recombinant INS-15 domain I expressed in E. coli (left panel) and purified
INS-15 domain I protein from E. coli (right panel). Lane M: molecular weight markers, Lane 1: lysate
from E. coli culture without IPTG induction, Lane 2: lysate from E. coli culture after IPTG induction,
with the expected product being indicated by an arrow, Lane 3: INS-15 domain I purified from the
lysate using Ni-NTA affinity chromatography.
2.2. Identification of Native INS-15
To characterize native INS-15, antibodies against the INS-15 domain I and an INS-15 polypeptide
were generated. In western blot analysis, antibodies against the INS-15 domain I reacted with a protein
of ~140 kDa weakly and several proteins smaller than 100 kDa in lysates of C. parvum sporozoites,
especially a band of ~23 kDa. As expected, they recognized the full-length 130 kDa recombinant protein,
fragments of it and two bands of ~25 kDa and ~23 kDa in recombinant INS-15 domain I (Figure 3a).
The pre-immune serum did not react with any of these proteins, confirming the specificity of the
antibodies to INS-15. Antibodies against INS-15 polypeptide produced similar profiles of reactivity
to native and recombinant INS-15 proteins, although the reactivity to the ~23 kDa band was much
weaker compared with antibodies against domain I (Figure 3b).
Figure 3. Expression of native INS-15 protein in C. parvum sporozoites. (a) Western blot analysis of
native INS-15 protein in crude sporozoite extract in the presence of protease inhibitors using antibodies
against the INS-15 domain I (left panel) and pre-immune serum (right panel). Lane M: molecular
weight markers, Lane 1: native proteins from sporozoites, Lane 2: purified full-length recombinant
INS-15 protein, Lane 3: purified INS-15 domain I. (b) Western blots analysis of native INS-15 protein
using anti-INS-15 polypeptide antibodies (left panel) and pre-immune serum (right panel). Lane M:
molecular weight markers, Lane 1: native proteins from sporozoites, Lane 2: purified full-length
recombinant INS-15 protein.
2.3. Expression of the INS-15 Gene and Protein in Life Cycle Stages
An analysis of the expression of the cgd3_4260 gene over a 72-h time course of C. parvum infection
in HCT-8 cells indicated that the highest INS-15 gene expression was at 2 h of the infection (Figure 4a).
The antibodies produced against the INS-15 domain I and polypeptide were used to examine
INS-15 expression in C. parvum sporozoites and intracellular stages using immunofluorescence
microscopy. In sporozoites, anti-INS-15 domain I antibodies reacted with the mid-anterior region
(Figure 4b, top panel). At 24 h and 48 h of cell culture, antibodies had the highest reactivity to the
part of merozoites opposite to the nucleus (Figure 4b, middle and bottom panel). A similar staining
pattern of sporozoites and merozoites were obtained with antibodies to the INS-15-specific polypeptide,
although the reactivity was slightly reduced compared with antibodies against domain I (Figure 4c).
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Figure 4. Expression of the INS-15 gene and protein in C. parvum. (a) Relative expression level of the
cgd3_4260 gene at various C. parvum cultivation time as determined by reverse transcription-qPCR. Data
from the Cryptosporidium 18S rRNA gene were used in data normalization. Data presented are mean ±
SD from three replicate assays, with qPCR analysis of each RNA extraction being performed in duplicate.
(b,c) Expression of INS-15 protein in C. parvum life cycle stages indicated by immunofluorescence
microscopy with anti-INS-15 domain I antibodies (b) or anti-INS-15-specific polypeptide antibodies c).
Sporozoites of C. parvum (top panel) used were obtained from excysted oocysts, while intracellular
developmental stages were obtained by cultivating C. parvum in HCT-8 cells for 24 h (middle panel)
and 48 h (bottom panel). The images were taken under differential interference contrast (DIC),
with nuclei being counter-stained with 4′, 6-diamidino-2-phenylindole (DAPI), parasites stained
by immunofluorescence with anti-INS-15 antibodies, and superimposition of the three (Merged).
Scale-bars: 2 µm.
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2.4. Inhibition of C. parvum Invasion by Anti-INS-15 Domain I Antibodies and Anti-INS-15 Polypeptide
Antibodies
The neutralizing effect of antibodies against INS-15 domain I and polypeptides on C. parvum
invasion were assessed using in vitro cell culture. In comparison with the control culture, the mean
parasite load was reduced significantly when the cell culture was inoculated with sporozoites treated
with antibodies against INS-15 domain I (Figure 5a). The inhibitory effect was 28.4% (26.0 ± 0.8 and
18.6 ± 0.2 parasites per 200× field for pre-immune serum and antibodies, respectively, t(2) = 13.373,
p = 0.006) at 1:1000 dilution, 32.2% (26.6 ± 0.6 and 18.0 ± 0.5 parasites per 200× field for pre-immune
serum and antibodies, respectively, t(2) = 107.250, p < 0.001) at 1:500 dilution, 34.6% (25.8 ± 1.4 and
16.9 ± 1.2 parasites per 200× field for pre-immune serum and antibodies, respectively, t(2) = 14.820,
p = 0.005) at 1:200 dilution, and 44.0% (26.4 ± 0.9 and 14.8 ± 1.2 parasites per 200× field for pre-immune
serum and antibodies, respectively, t(2) = 74.389, p < 0.001) at 1:100 dilution. In contrast, the inhibitory
effect of antibodies to the INS-15 polypeptide was 0.9% (20.8 ± 1.5 and 20.6 ± 1.7 parasites per 200×
field for pre-immune serum and antibodies, respectively, t(2) = 1.104, p = 0.385) at 1:1000 dilution, 9.6%
(20.3 ± 0.7 and 18.4 ± 2.4 parasites per 200× field for pre-immune serum and antibodies, respectively,
t(2) = 1.880, p = 0.201) at 1:500 dilution, 16.6% (20.6 ± 1.8 and 17.2 ± 2.3 parasites per 200× field for
pre-immune serum and antibodies, respectively, t(2) = 8.883, p = 0.012) at 1:200 dilution, and 17.9%
(21.4 ± 1.1 and 17.6 ± 1.7 parasites per 200× field for pre-immune serum and antibodies, respectively,
t(2) = 6.352, p = 0.024) at 1:100 dilution (Figure 5b).
Figure 5. Partial neutralization of C. parvum invasion by antibodies against INS-15. Hypochlorite-treated
oocysts were pre-incubated with 1:1000, 1:500, 1:200, and 1:100 dilutions of antibodies against the
INS-15 domain I (a), the INS-15-specific polypeptide antibodies (b), with pre-immune serum or culture
medium alone as controls. Parasite loads per 200×microscope field were calculated and compared
among treatment groups. Data presented are mean ± SD from three replicate assays. The * or **
symbol above the treatment group indicates the difference between the treated and untreated groups is
statistically significant at p < 0.05 and p < 0.01, respectively.
3. Discussion
Insulinase-like proteases have been reported in numerous apicomplexan parasites and appear
to play important roles in the invasion and growth of parasites. Among them, falcilysin was found
mostly in the apicoplast of P. falciparum [20,21], toxolysin-1 was localized in the rhoptry and secreted
during host cell invasion of T. gondii [15], while toxolysin-4 was localized in the micronemes and
secreted in the response to elevated calcium [16]. Cryptosporidium spp. appear to have many more
INS than other apicomplexans [10]. Thus far, the function of this large family of proteins remains
unclear. Recently, we characterized the function of a C. parvum-specific INS, INS-20-19, which has only
two of the four domains of functional insulinases [19]. In this study, we identified, expressed, and
characterized INS-15 of C. parvum, which has all four domains.
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Data from the present study suggest that INS-15 may participate in the invasion of host cells
by C. parvum. The INS-15 gene has peak expression during the early period of the life cycle of
C. parvum. Furthermore, the INS-15 protein is expressed in the mid-anterior region of sporozoites
and a part of merozoites opposite to the nucleus, suggesting that INS-15 may play similar roles in
invasive stages of the parasite. In agreement with the potential involvement of INS-15 in the invasion
of host cells, antibodies against the INS-15 domain I reduced the invasion of HCT-8 cells by over
40%. The neutralization effect of the polyclonal antibodies could be a combined effect on both INS-15
and INS-16, which have high sequence similarity. Nevertheless, the modest reduction in invasion is
expected, because C. parvum has several other INS with all four domains of functional insulinases,
and it is known that most apicomplexans use multiple strategies for invasion [22]. Taken together,
these data suggest that INS-15 could be involved in the invasion on the early growth of parasites [23].
Further studies of the subcellular localization of INS-15 and gene ablation using the CRISPR/Cas9
system or gene overexpression are needed to elucidate the exact biological functions of the protein.
In comparison with INS-20-19, INS-15 is a classic insulinase that is present in all Cryptosporidium
species and has shown a different expression profile. The gene for it is located in a cluster of 11 INS
genes in chromosome 3 [10,19]. In contrast, INS-20-19 is a unique protein that is absent in C. hominis
and has only two of the four domains of functional insulinases. The gene encoding it is located in the
subtelomeric region of chromosome 6 [10,19]. Although the INS-20-19 and INS-15 genes both have
peak expression at 2 h post-infection in vitro, the expression of the INS-20-19 protein appears in the
apical region of sporozoites and the entire surface of merozoites, while the INS-15 protein is expressed
in the mid-anterior region of sporozoites and possibly also merozoites. In this study, two antibodies
were used to localize the expression of INS-15. INS-15 expression was localized to the mid-anterior
region of sporozoites and the area of merozoites opposite to the nucleus when antibodies against the
INS-15 domain I were used in immunofluorescence microscopy. When the antibodies against the
INS-15-specific polypeptide were used, the expression of INS-15 appeared to be more confined in both
sporozoites and merozoites. Thus, INS-15 and INS-16 may be expressed in different organelles of
the parasites.
INS-15 protein could be possibly involved in peptide degradation in C. parvum. As predicted
in silico, INS-15 has four conserved domains common to M16A proteases. The domain I contains an
active site characterized by the zinc-binding motif HYLEH, while domains II and IV have homology to
the M16A inactive catalytic domains of insulin-like proteases, suggests that INS-15 is a functional M16A
protease [24]. Pf SPP, an M16C protein in P. falciparum, cleaves the transit peptide of plastid-targeted
proteins [21,25,26]. Falcilysin is another M16C protein in P. falciparum and was shown to degrade
transit peptide in the apicoplast [20]. Although Cryptosporidium spp. have lost the apicoplast, INS-15
might also participate in peptide degradation in C. parvum. In addition, the INS-15 protein is expressed
from sporozoites to 48 h in vitro culture. This suggests that INS-15 may exert its functions in multiple
life cycle stages, including the initial invasion of host cells by sporozoites, parasite multiplication after
the entry, and secondary invasion of neighboring cells by merozoites.
There appears to be proteolytic processing of INS-15 during its expression in E. coli. Multiple
products were observed in the SDS-PAGE analysis of the recombinant protein expressed in E. coli.
Attempts were made to improve the expression of the full-length INS-15 using BL21-Codon
plus(DE3)-RIPL cells or optimizing the codons of cgd3_4260 to those of E. coli. However, no significant
improvements in protein expression were observed. This was also observed in the expression of human
insulinase in E. coli [27]. In western blot analysis of the native INS-15 protein in C. parvum sporozoites,
several lower bands with molecular weight of ~60 kDa, ~38 kDa, and ~23 kDa were also observed. It is,
therefore, possible that the INS-15 sequence contains proteolytic cleave sites. A pro-domain cleave
site, SΦXE/D (in which Φ is hydrophobic and X is any amino acid), which was first characterized in
ROP1 [28,29], is present in toxolysin-1 [15]. INS-15 apparently has two such cleavage sites, with the
sequence SIID in amino acids 375–378 and SIRD in amino acids 923–926. In theory, their cleavage in
the full-length INS-15 protein could generate fragments of ~29 kDa, 40 kDa and 64 kDa, which are
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similar in size to INS-15 protein fragments we observed. Taken together, the INS-15 protein may be
post-translationally processed to exert its multiple biological activities in ways similar to toxolysins.
4. Materials and Methods
4.1. Parasite and Cell Line
Oocysts of C. parvum IOWA isolate were purchased from Waterborne, Inc. (New Orleans, LA,
USA) and stored at 4 ◦C for less than two months since their harvest. Prior to use, they were treated
with 0.5% sodium hypochlorite on ice for 10 min and washed three times with phosphate-buffered
saline (PBS) by centrifugation. Genomic DNA was extracted from C. parvum oocysts using the Qiagen
DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany).
Human ileocecal adenocarcinoma HCT-8 cells were obtained from the Chinese Academy of
Sciences Shanghai Branch. For in vitro experiments, HCT-8 cells were seeded into 12-well cell culture
plates and cultured in RPMI 1640 medium containing 10% fetal bovine serum (FBS), 100 units/mL
penicillin and 100 µg/mL streptomycin at 37 ◦C until ~90% confluence. Hypochlorite-treated oocysts
were suspended in 2% FBS-supplemented RPMI 1640 medium and added into the plates at 5 × 105
oocysts/well. After incubation for 2 h, uninvaded parasites were washed off the culture with PBS.
Fresh 2% FBS-supplemented RPMI 1640 medium was added to the culture, which was maintained for
a specified duration depending on the assay.
4.2. Cloning, Expression and Purification of INS-15 and INS-15 Domain I
Domains within INS-15 (cgd3_4260) were predicted using Pfam 31.0 (http://pfam.xfam.org).
The full cgd3_4260 gene was amplified from genomic DNA of C. parvum IOWA isolate using
primers 5′-GGCCCATGGGGTGTATTTCATTATTA-3′ (the NcoI restriction site underlined) and
5′-GGCCTCGAGTATTGCATTAAAAACATTC-3′ (the XhoI restriction site underlined), while its
domain I region was amplified using 5′-CGCGGATTCAGATATATTAAGTTGA-3′ (the BamHI
restriction site underlined) and 5′-CCGCTCGAGGATTAAAACGAAAG-3′ (the XhoI restriction site
underlined). The PCR was performed in a GeneAmp 9700 (Applied Biosystems) with the following
cycling condition: 95 ◦C for 5 min, 35 cycles of 95 ◦C for 45 s, 55 ◦C for 45 s, and 72 ◦C for 105 s, and
72 ◦C for 7 min. The PCR products generated were cloned into the pET-28a vector (Novagen, Madison,
WI, USA). The recombination plasmids generated were used to transform Escherichia coli DH5α cells.
The bacterial colonies were screened by PCR using the T7/T7t universal primers, with positive colonies
being sequenced to confirm their identity and sequence accuracy.
The plasmid containing the correct sequence of the cgd3_4260 gene or the domain I fragment
was transformed into E. coli BL21(DE3) cells or Rosetta(DE3) cells for protein expression. In some
experiments, codons in the cgd3_4260 gene were modified to E. coli ones using the gene synthesis
approach prior to the transformation of the BL21-Codon plus(DE3)-RIPL cells. The BL21(DE3) cells
were cultured in LB medium containing 100 µg/mL kanamycin at 37 ◦C, while the Rosetta(DE3) or
BL21-Codon plus(DE3)-RIPL cells were cultured in LB medium containing 100 µg/mL kanamycin and
34 µg/mL chloramphenicol at 37 ◦C. After the OD600 reached 0.6–0.8, the expression of INS-15 or INS-15
domain I in E. coli was induced by adding 0.1 mM IPTG to the culture at 18 ◦C for 8 h. The expression
level of the target protein was evaluated using the SDS-PAGE with Coomassie blue G-250 staining.
For the purification of INS-15 and INS-15 domain I, cultured E. coli cells were harvested by
centrifugation and lysed by sonication on ice. The lysate was centrifuged and the pellet was dissolved
in PBS buffer containing 8 M urea. After centrifugation again, the supernatant was filtered through
a 0.45-µm cellulose acetate membrane filter (Millipore, Billerica, MA, US), and loaded onto Ni-NTA
beads (Novagen, Madison, WI, USA) at 16 ◦C and 90 rpm for 4 h. The beads were washed with
10 volumes of 6 M PBS-buffered urea containing 20 mM imidazole and eluted with 6 volumes of
6 M PBS-buffered urea containing 250 mM imidazole. The purified protein was examined using
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SDS-PAGE with Coomassie blue G-250 staining and analyzed for identity using Matrix-Assisted Laser
Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF-MS).
4.3. Preparation of Antibodies Against INS-15 Domain I and Polypeptide
Polyclonal antibodies against the INS-15 domain I and an INS-15 specific polypeptide (amino
acid sequence CEITTKTYDFDWKKN selected based on sequence alignment of INS-15 and INS-16
(https://www.ebi.ac.uk/Tools/msa/clustalo/)) (Figure 1b) were raised in pathogen-free rabbits by
Genscript Ltd. (Nanjing, China). Three hundred micrograms of the recombinant protein or polypeptide
conjugated with keyhole limpet hemocyanin were emulsified with Freund’s complete adjuvant and
used in the intramuscular immunization of rabbits. Two subsequent booster immunizations were
administered at 2-week intervals with 300 µg of each antigen emulsified in Freund’s incomplete
adjuvant. Two weeks after the last immunization, the rabbits were sacrificed, sera collected, and the
polyclonal IgG antibodies purified using an affinity chromatographic column conjugated with INS-15
domain I or INS-15 polypeptide.
4.4. Western Blot Analysis of Native INS-15
To assess the expression of the native INS-15, oocysts treated with 0.5% sodium hypochlorite were
suspended in PBS buffer containing 0.75% taurodeoxycholic acid and 0.25% trypsin and incubated
at 37 ◦C for 1 h. The sporozoites released were collected by centrifugation and resuspended in PBS
containing 1% protease inhibitor cocktail (Merck, Darmstadt, Germany). They were lysed by adding
a protein-loading buffer (Yeasen, Shanghai, China) and boiling for 5 min. Proteins (from ~5 × 106
sporozoites/lane) in the lysate were separated on SDS-PAGE and transferred onto nitrocellulose
membranes. The latter were blocked with 5% nonfat milk-PBST for 2 h and incubated with anti-INS-15
domain I antibodies (~0.5 µg/mL), anti-INS-15 polypeptide antibodies (~1.5 µg/mL), or pre-immune
serum (1:1000) for 2 h. Horseradish peroxidase (HRP)-conjugated goat-anti-rabbit antibodies (Earthox,
Millbrae, CA, USA) were used at 1:5000 as the secondary antibodies in the western blot analysis. After
1-h incubation and three washes with PBST, the blots were treated with an enhanced chemiluminescent
reagent (Thermo Fisher, Rockford, IL, USA) and analyzed with a Tanon 5200 (Tanon, Shanghai, China).
4.5. Quantitative Analysis of cgd3_4260 Gene Expression
The relative expression levels of the cgd3_4260 gene in intracellular parasites developed in
HCT-8 cells for 2–72 h were evaluated by qPCR. Parallel data on the expression of the 18s rRNA
(Cp18s) gene of C. parvum were used in data normalization. Each of the qPCR reactions contained
0.1 mM primers, 1 µL of cDNA synthesized from 2 µg of total RNA using the GoScript Reverse
Transcription System (Promega, Beijing, China), and 10 µL of SYBR Green PCR Mix (TOYOBO, Osaka,
Japan) in a 20-µL reaction. The PCR reaction was conducted on a LightCycler 480 (Roche, Basel,
Switzerland), with the following cycling conditions: 95 ◦C for 3 min and 45 cycles of 95 ◦C for 30 s,
58 ◦C for 30 s, and 72 ◦C for 30 s. The primers used included 5′-AGCCGCACTTTCGATGTTTT-3′
and 5′-ATCTGATAGCTCGTGAGTCAC-3′ for the cgd3_4260 gene (amplicon: 154 bp), and
5′-CTCCACCAACTAAGAACGGCC-3′ and 5′-TAGAGATTGGAGGTTGTTCCT-3′ for the 18s rRNA
gene (amplicon: 256 bp) [18]. The expression level of the cgd3_4260 gene in infected HCT-8 cells was
calculated using the 2−44CT method [30]. The data presented were from three independent experiments
performed in duplicate.
4.6. Immunofluorescence Assay (IFA)
Sporozoites resuspended in PBS were dried onto microscope slides, whereas intracellular stages
of C. parvum in HCT-8 cells were grown on coverslips for 24 and 48 h. These slides or coverslips were
fixed with methanol at room temperature for 15 min. After three washes with PBS, the fixed sporozoites
or cells were treated with 0.5% Triton-X in PBS for 15 min and blocked for nonspecific binding with
5% BSA in PBS for 1 h. After three washes with PBS, they were incubated with antibodies against
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INS-15 domain I (~0.6 µg/mL) or INS-15 polypeptide (~3.9 µg/mL) in 5% BSA-PBS for 1 h, followed
by incubation with Alexa Fluor 594-conjugated Goat Anti-rabbit IgG (Cell Signaling Technology,
Beverly, MA, US) in 5% BSA-PBS at 1:400 for another hour. After three washes, the slides or coverslips
were counterstained with the nuclear stain 4′,6-diamidino-2-phenylindole (DAPI, Sigma, St Louis,
MO, USA). After three more washes, the slides or coverslips were mounted with No-Fade Mounting
Medium (Booster, Wuhan, China) and examined using differential interference contrast (DIC) and
fluorescence microscopy on a BX53 microscope (Olympus, Tokyo, Japan).
4.7. Invasion Neutralization Assay
Hypochlorite-treated oocysts were incubated in culture medium containing increasing dilutions
of polyclonal antibodies or pre-immune serum at 37 ◦C for 15 min, with a culture medium only as
the negative control. The mixture was inoculated onto HCT-8 cells grown on coverslips to ~90%
confluence in 12-well plates as described above. After 2-h incubation, the cells were washed three
times and incubated for an additional 22 h in fresh culture medium. The coverslips were blocked with
5% BSA in PBS, stained with Cy3-labeled Sporo-Glo antibodies (Waterborne), and examined under the
BX53 immunofluorescence microscope. Images of 50 microscope fields per coverslip were captured
randomly under 200×, and the number of the parasites in the fields was quantified using ImageJ
(https://imagej.nih.gov/ij/). The percent of inhibition of infection was calculated using the following
formula: (1 − [No. of parasites after antibody treatment/No. of parasites after pre-immune serum
treatment]) × 100%. The mean percent inhibition was calculated based data from three independent
experiments. A paired t-test implemented in SPSS Statistics Version 23.0 (IBM Corp., Armonk, NY,
USA) was used to compare the means of two groups.
5. Conclusions
We have expressed an INS of C. parvum, INS-15, one of the few INS in the parasite that have
all four domains of classic INS. Our results indicated that INS-15 is expressed in the mid-anterior
region of sporozoites and the area of merozoites opposite to the nucleus, and antibodies against its first
domain partially neutralized the invasion of host cells. Further studies are needed to differentiate the
neutralization effects of antibodies against INS-15 from those by antibodies against INS-16 before we
have a better appreciation of the biological functions of INS in Cryptosporidium spp.
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